Načítá se...
Prolonged therapy with cabazitaxel in an octogenarian with metastatic castration-resistant prostate cancer
In the phase III TROPIC trial, cabazitaxel in combination with prednisone was compared to mitoxantrone with prednisone in patients with metastatic castration-resistant disease (mCRPC) that had received previous therapy with docetaxel. Cabazitaxel therapy was associated with an improvement in overall...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845876/ https://ncbi.nlm.nih.gov/pubmed/22575202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2012.03.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|